Harms, Mirja
Gilg, Andrea
Ständker, Ludger
Beer, Ambros J.
Mayer, Benjamin
Rasche, Volker
Gruber, Christian W.
Münch, Jan
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC1279, CRC1279, CRC1279, CRC1279, CRC1279, CRC1279)
Baden-Württemberg Stiftung
European Research Council
International Graduate School in Molecular Medicine Ulm
Projekt DEAL
Article History
Received: 26 February 2020
Accepted: 7 September 2020
First Online: 29 September 2020
Competing interests
: A.G., A.B., B.M, V.R. and C.W.G. declare no competing interest. L.S., M.H. and J.M. are coinventors of patents claiming the use of EPI-X4 (ALB408-423) and derivatives for the therapy of CXCR4 associated diseases.